Cancer Center Support Grant
癌症中心支持补助金
基本信息
- 批准号:10643036
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
Since the last competitive review of this Cancer Center Support Grant (CCSG) in 2012, the NCI-designated
Perlmutter Cancer Center (PCC), previously NYU Cancer Institute, has weathered the devastation of Superstorm
Sandy and emerged into a period of profound transformation and expansion. Propelled by a transformative gift
from Laurie and Isaac Perlmutter, renewed and enhanced institutional support from the NYU Langone Health
system (NYULH) and a new Director, we have overhauled our leadership team, expanded our clinical and
research facilities, and developed a new strategic vision and began implementing a new Strategic Plan. Guided
by this plan, our Scientific Programs and Shared Resources have been restructured, and we embarked on a
major recruitment campaign that has yielded 12 additional new leadership and/or senior faculty recruits, 15 other
new cancer center faculty recruits, and 68 new members overall. Under revised, more stringent criteria,
membership has been streamlined to 180 full members and 56 associate members. Members carry out research
as part of 5 Scientific Programs, Cancer Genome Dynamics, Cancer Cell Biology, Tumor Immunology,
Melanoma, or Epidemiology and Cancer Control, assisted by 10 Shared Resources and 2 Developing Shared
Resources. Our clinical trials office has been reorganized and substantially expanded under new leadership and
a new Phase I unit has opened. Subsequently, trial availability, quality, and accrual have increased, while the
time to trial opening has been markedly reduced. In line with our increased geographic scope and patient
population, we have redefined and enlarged our catchment area. Aided by the creation of a new Department of
Population Health at NYU Langone School of Medicine and the College of Global Public Health at the NYU main
campus, our Population Sciences research has increased in breadth and quality. Most importantly, our laboratory
scientists have made paradigm-shifting discoveries, our clinicians have led multiple practice-changing trials, and
our population scientists have yielded new insights into the causes of cancer and how to control the disease,
contributed to major public health policy changes and initiatives, and established new community outreach
programs that address the specific cancer burdens and health disparities in our catchment area. Although PCC
is located in a city with four other NCI-designated cancer centers, our catchment area differs substantially from
the others: we are the major provider to lower Manhattan, and have expanded into Brooklyn, the largest and
fastest growing borough in New York City, as well as to Queens and Long Island.
项目摘要
自2012年对癌症中心支持补助金(CCSG)的最后一次竞争评论以来,NCI指定
Perlmutter癌症中心(PCC),此前纽约大学癌症研究所(PCC)曾经历过超级风暴的破坏
桑迪(Sandy)进入了深刻的转变和扩张时期。由变革性礼物推动
来自Laurie和Isaac Perlmutter,从NYU Langone Health获得了续签和增强的机构支持
系统(NYULH)和新任主任,我们已经大修了我们的领导团队,扩大了我们的临床和
研究设施,并制定了一种新的战略愿景,并开始实施新的战略计划。指导
根据该计划,我们的科学计划和共享资源已经进行了重组,我们开始了
重大招聘运动,还产生了12个新的领导和/或高级教师新兵,其他15名
新的癌症中心教职员工,总体上有68名新成员。在经过修订,更严格的标准下,
成员资格已简化为180名正式成员和56名员工。成员进行研究
作为5个科学计划的一部分,癌症基因组动力学,癌细胞生物学,肿瘤免疫学,
黑色素瘤或流行病学和癌症控制,在10个共享资源和2种共享的共享资源的协助下
资源。我们的临床试验办公室已在新的领导下进行了重组和大幅扩展
一个新的I期单元已开放。随后,试用的可用性,质量和应计增加,而
审判开放的时间已明显减少。与我们增加的地理范围和患者一致
人口,我们重新定义并扩大了我们的集水区。在创建新部门的帮助下
NYU Langone医学院和NYU Main全球公共卫生学院的人口健康
校园,我们的人口科学研究在广度和质量方面有所提高。最重要的是,我们的实验室
科学家已经进行了范式转移发现,我们的临床医生领导了多次练习的试验,并且
我们的人口科学家已经对癌症原因以及如何控制疾病的原因产生了新的见解,
为重大的公共卫生政策变更和倡议做出了贡献,并建立了新的社区宣传
解决我们集水区特定癌症负担和健康差异的计划。虽然PCC
我们的集水区与其他四个NCI指定的癌症中心相同
其他:我们是下曼哈顿的主要提供商,并已扩展到布鲁克林,最大的是布鲁克林
纽约市以及皇后区和长岛的增长最快的自治市镇。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
BENJAMIN G. NEEL的其他基金
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
HER2 阳性乳腺癌耐药者的分子本体论 - 重新提交 - 1
- 批准号:1054502510545025
- 财政年份:2022
- 资助金额:$ 15万$ 15万
- 项目类别:
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
HER2 阳性乳腺癌耐药者的分子本体论 - 重新提交 - 1
- 批准号:1039186610391866
- 财政年份:2022
- 资助金额:$ 15万$ 15万
- 项目类别:
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
非小细胞肺癌中单独使用和联合使用 SHP2 抑制剂的反应和耐药性
- 批准号:1053192910531929
- 财政年份:2020
- 资助金额:$ 15万$ 15万
- 项目类别:
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
非小细胞肺癌中单独使用和联合使用 SHP2 抑制剂的反应和耐药性
- 批准号:1031623710316237
- 财政年份:2020
- 资助金额:$ 15万$ 15万
- 项目类别:
Human Shp2 (Ptpn11) mutations and cardiac valve development
人类 Shp2 (Ptpn11) 突变与心脏瓣膜发育
- 批准号:73190317319031
- 财政年份:2007
- 资助金额:$ 15万$ 15万
- 项目类别:
Human Shp2 (Ptpn11) mutations and cardiac valve development
人类 Shp2 (Ptpn11) 突变与心脏瓣膜发育
- 批准号:76296407629640
- 财政年份:2007
- 资助金额:$ 15万$ 15万
- 项目类别:
Human Shp2 (Ptpn11) mutations and cardiac valve development
人类 Shp2 (Ptpn11) 突变与心脏瓣膜发育
- 批准号:76148527614852
- 财政年份:2007
- 资助金额:$ 15万$ 15万
- 项目类别:
Human Shp2 (Ptpn11) mutations and cardiac valve development
人类 Shp2 (Ptpn11) 突变与心脏瓣膜发育
- 批准号:77895547789554
- 财政年份:2007
- 资助金额:$ 15万$ 15万
- 项目类别:
EM LOCALIZATION OF PTP1B & RTK & PTP1B INTERACTIONS
PTP1B 的电子显微镜定位
- 批准号:73580547358054
- 财政年份:2006
- 资助金额:$ 15万$ 15万
- 项目类别:
EM LOCALIZATION OF PTP1B & RTK & PTP1B INTERACTIONS
PTP1B 的电子显微镜定位
- 批准号:71813507181350
- 财政年份:2005
- 资助金额:$ 15万$ 15万
- 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:1074953910749539
- 财政年份:2024
- 资助金额:$ 15万$ 15万
- 项目类别:
University of Wisconsin Prostate SPORE
威斯康星大学前列腺孢子
- 批准号:1055539810555398
- 财政年份:2023
- 资助金额:$ 15万$ 15万
- 项目类别:
JAX Diversity Action Plan (DAP) Post-Baccalaureate Program in Genomics (gDAP)
JAX 多样性行动计划 (DAP) 基因组学学士后计划 (gDAP)
- 批准号:1055558810555588
- 财政年份:2023
- 资助金额:$ 15万$ 15万
- 项目类别:
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:1055811910558119
- 财政年份:2023
- 资助金额:$ 15万$ 15万
- 项目类别:
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders
iTEST:内省准确性作为精神障碍功能的新目标
- 批准号:1064240510642405
- 财政年份:2023
- 资助金额:$ 15万$ 15万
- 项目类别: